scispace - formally typeset
S

Steinar Lundgren

Researcher at Norwegian University of Science and Technology

Publications -  98
Citations -  4551

Steinar Lundgren is an academic researcher from Norwegian University of Science and Technology. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 37, co-authored 95 publications receiving 3885 citations.

Papers
More filters
Journal Article

Distribution of 4-Hydroxy-N-desmethyltamoxifen and Other Tamoxifen Metabolites in Human Biological Fluids during Tamoxifen Treatment

TL;DR: Several metabolites of tamoxifen, including 4-hydroxylated, conjugated metabolites (Y, B, and BX), and N-desdimethyltamxifen (metabolite Z) were identified and their concentrations determined in fluids and feces from patients receiving chronic tamox ifen treatment, suggesting that the serum levels are production rate limited.
Journal ArticleDOI

Characterization of neoplastic and normal human breast tissues with in vivo 1H MR spectroscopy

TL;DR: Choline‐containing compounds were detected in 9 of 11 carcinomas and in 2 of 11 benign lesions, demonstrating that choline compounds can be detected by in vivo 1H MRS in breast tissue under physiological conditions.
Journal ArticleDOI

Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters.

TL;DR: High‐resolution magic angle spinning MR spectroscopy of tissue biopsies provides detailed information on metabolic composition of breast cancer tissue and tumor samples could be distinguished from non‐involved samples based on relative intensities of signals from GPC, PC and choline in 1H HR MAS spectra.
Journal ArticleDOI

The effect of exercise on fatigue and physical functioning in breast cancer patients during and after treatment and at 6 months follow-up: A meta-analysis.

TL;DR: This systematic review found that an exercise intervention program can produce short-term improvements in physical functioning and can reduce fatigue in breast cancer patients, however, more studies are needed to confirm the time-dependent observations in this study.
Journal ArticleDOI

Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial

TL;DR: For patients with early breast cancer who met the trial selection criteria, risk adapted immediate single dose TARGIT-IORT during lumpectomy was an effective alternative to EBRT, with comparable long term efficacy for cancer control and lower non-breast cancer mortality.